The hyaluronan-mediated motility receptor (HMMR, also known as RHAMM) interacts with BRCA1 to regulate cell division and apicobasal polarization of mammary epithelial cells10,11, and is a potential modifier of BRCA1-associated breast cancer risk11,12. This evidence concerns the gene BRCA1 and breast carcinoma.